U.S. Veterinary CRO and CDMO Market projected to reach USD 5.48 billion by 2035 on mRNA vaccine and biologics outsourcing; Europe to reach USD 4.37 billion as regulatory requirements and established animal-health outsourcing support demand.

Austin, United States, Aug. 24, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the global Veterinary CRO and CDMO Market was valued at USD 7.38 billion in 2025 and is projected to reach USD 19.61 billion by 2035, expanding at a CAGR of 8.84% from 2026 to 2035. Growth is being supported by increased cases of diseases among animals, humanization of pets, increasing population of livestock, and outsourcing of drug development research & development, regulatory support, formulation, process development, clinical testing, and commercial manufacturing.

Animal health companies are increasingly opting for integrated veterinary CRO and CDMO services in areas such as preclinical and clinical testing, pharmacokinetics, regulatory support, formulation, process development, and large scale manufacturing of veterinary pharmaceutical products. As an example of this outsourcing strategy, the collaboration between WuXi AppTec and Bayer, which took place in May 2023, has been cited.

Download a Free Sample of the Veterinary CRO and CDMO Market Report: https://www.snsinsider.com/sample-request/6019

Veterinary CRO and CDMO Market Growth Drivers: Animal Disease Prevalence, Pet Humanization and Outsourcing

The increasing prevalence of diseases among animals, such as cancer and zoonoses, acts as one of the core demands drivers in the veterinary CRO and CDMO markets. Application of the WHO One Health approach points to the importance of investing in veterinary drugs for preventing the spread of zoonotic infections, supporting government-funded animal disease research, and regular purchase of CRO services. Moreover, zoonotic pathogen surveillance initiatives could encourage research outsourcing and increase the development of veterinary drugs.

Veterinary CRO and CDMO Market: Key Takeaways

  • Leading Service Type: CDMO Services (~85.5% share)
  • Leading Animal Type: Livestock Animals (~63.0% share)
  • Leading Application: Medicine/Pharmaceuticals
  • Leading End User: Pharmaceutical & Biotechnology Companies (~58.0% share)
  • Largest Regional Market: North America
  • Fastest-Growing Regional Market: Asia Pacific

Veterinary CRO and CDMO Market Regional Analysis

North America was the dominant region when it comes to market share in 2025 due to the influence of companies, such as Charles River Laboratories, Covance (Labcorp), MPI Research (Inotiv), and WuXi AppTec's domestic subsidiary due to the outsourcing programs of Zoetis, Merck Animal Health, Elanco, and Boehringer Ingelheim Vetmedica. Around 87.4% of North America's revenues came from the United States in 2025 due to the APHIS veterinary biologics regulations in place by USDA and FDA's Center for Veterinary Medicine drug approval process, while around 12.6% came from Canada.

The U.S. Veterinary CRO & CDMO Market value was around USD 2.06 Billion in 2025 and is estimated to rise to around USD 5.48 Billion by 2035, growing at a CAGR of around 8.63% between 2026 and 2035. The market will be boosted by the exceptional clustering of animal health companies' headquarters in the U.S. and continuous outsourcing of CDMOs through mRNA vaccines and biologics pipeline.

Europe Veterinary CRO & CDMO Market size is projected to reach around USD 2.14 Billion in 2025 and grow further to USD 4.37 Billion in 2035 at a CAGR of around 7.40% during 2026-2035 and is expected to account for approximately 29.0% of global market revenue share in 2025. Europe is an advanced veterinary CRO and CDMO market where the regulations on veterinary medicines of EMA, Boehringer Ingelheim Vetmedica GmbH’s market position in Germany, and the European animal health industry’s culture of outsourcing shape institutional demand.

The Asia-Pacific region is expected to register the fastest growth during the forecast period due to the growing animal health sector in China, the enormous livestock output in India, and the highly developed veterinary pharmaceuticals market in Japan. China contributed around 44.8% of the Asia-Pacific revenue in 2025 owing to CDMO outsourcing by the local animal health firms as well as food safety research investments by the government.

Veterinary CRO and CDMO Market Segmentation

By Service Type

CDMO services held nearly 85.5% share of the market in 2025 due to structural advantages of the veterinary pharmaceutical industry favoring outsourcing with outsourcing motives that include high cost and complexity of manufacturing process and the need to have specialized formulations for specific species. The fastest-growing segment in the market is the CRO services which are growing due to rising incidences of animal disease, oncology, and specialty medicines of companion animals.

By Animal Type: Livestock Leads, Companion Animals Gain Momentum

The Livestock Animals category accounted for the largest market share of around 63.0% in 2025, considering the size of the global food production industry, wherein the health care of cattle, poultry, and swine in this sector is behind the largest value purchase of veterinary pharmaceuticals, backed by the production of 239.30 million tons of milk production from India during 2023-24. The Companion Animals category is projected to witness the highest growth rate among all types of animals on account of the increasing number of pet humanization globally.

By Application: Pharmaceuticals Lead; Biologics and Vaccines Accelerate

Medicine/Pharmaceuticals has the highest application share in 2025, as there are well-established portfolios of antiparasitic, anti-infective, and anti-inflammatory veterinary products that drive continuous volume-based manufacturing from CDMOs. The Biologics/Vaccines & Immunologics market segment has been witnessing the fastest growth as the mRNA vaccine technology finds its way into commercial use due to its success in human medicine after the pandemic.

By End User

Pharmaceutical and Biotechnology Companies had the largest market share of about 58.0% in 2025 owing to the heavy investment made in outsourcing in order to reduce the costs associated with conducting trials and obtain regulatory approval. The fastest-growing end-user segment is Animal Health Companies due to the growing outsourcing trend among dedicated animal health firms.

Explore the Complete Veterinary CRO and CDMO Market Report, Segmentation and Forecast: https://www.snsinsider.com/reports/veterinary-cro-and-cdmo-market-6019

Veterinary CRO and CDMO Market: Leading Companies Covered

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health Inc.
  • Boehringer Ingelheim Vetmedica GmbH
  • Ceva Santé Animale
  • Charles River Laboratories International Inc.
  • Covance Inc.
  • WuXi AppTec Co., Ltd.
  • MPI Research
  • Pharmacyclics
  • EUROVET Animal Health BV
  • Virbac S.A.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Kindred Biosciences
  • Neogen Corporation
  • Bio Pharma Services Inc.
  • Absorption Systems
  • Bioxcel Therapeutics
  • Pacific Biotech International

Recent Veterinary CRO and CDMO Market Developments

  • 2024: Zoetis expanded its CDMO outsourcing programme with new manufacturing partnerships for its veterinary mRNA vaccine pipeline, targeting novel RNA-based vaccines for swine and poultry respiratory diseases.
  • 2024: Charles River Laboratories expanded its veterinary CRO capabilities with new large animal facility investment targeting cattle, swine, and equine clinical study services.

What Buyers Get in the Veterinary CRO and CDMO Market Report

  • CRO & CDMO SERVICE TYPE PERFORMANCE METRICS – helps you understand outsourcing trends across veterinary research, development and manufacturing services and adoption across animal health organizations globally.
  • VETERINARY DRUG DEVELOPMENT & CLINICAL RESEARCH METRICS – helps you evaluate preclinical research, clinical development investment trends and specialist veterinary research provider competitive positioning globally.
  • CONTRACT MANUFACTURING & COMMERCIALIZATION METRICS – helps you analyze veterinary pharmaceutical manufacturing outsourcing, production capacity requirements and commercialization-driven demand across animal health companies globally.
  • COMPANION & LIVESTOCK ANIMAL HEALTH METRICS – helps you uncover growth in outsourced development services across companion animal and livestock therapeutics and veterinary healthcare organizations globally.
  • BIOLOGICS & VETERINARY VACCINE DEVELOPMENT METRICS – helps you identify growth opportunities in veterinary biologics, vaccine development, specialized manufacturing and advanced animal health product pipelines globally.
  • COMPETITIVE LANDSCAPE & VETERINARY OUTSOURCING EXPANSION METRICS – helps you gauge the competitive strength of key market players based on service portfolio breadth, development capabilities and geographic operational footprint globally.

Buy the Veterinary CRO and CDMO Market Report with Competitive Analysis and 2035 Forecast: https://www.snsinsider.com/checkout/6019

Veterinary CRO and CDMO Market Report Scope and Forecast

Report AttributesDetails
Market Size in 2025USD 7.38 Billion
Market Size by 2035USD 19.61 Billion
CAGRCAGR of 8.84% From 2026 to 2035
Base Year2025
Forecast Period2026-2035
Historical Data2022-2024
Key Segments• by Service Type (CDMO Services/Drug Development & Manufacturing, CRO Services/Contract Research & Clinical Trials)
• by Animal Type [Livestock Animals (Cattle, Poultry, Swine, Aquaculture), Companion Animals (Dogs, Cats, Horses, Others)]
• by Application (Medicine/Pharmaceuticals, Biologics/Vaccines & Immunologics, Feed Additives, Diagnostics, Others)
• by End User (Pharmaceutical & Biotech Companies, Veterinary Research Institutions, Government & Regulatory Bodies, Animal Health Companies, Others)
Regional Analysis/CoverageNorth America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Related Veterinary and Animal Health Market Reports

Veterinary Clinical Trials Market Size 2026

Veterinary Reference Laboratory Market Outlook 2026

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Growth 2026

Veterinary Medicine Market Trends 2026

About SNS Insider

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Rohan Jadhav - Principal Consultant
Phone: +1-315-961-9094 (US)
Email: info@snsinsider.com